MRC1 and myeloid sarcoma: Importantly, this functional shift can also be observed in MS patient lesions, with myelin-laden macrophages expressing high levels of M2 associated CD163 and CD206 [54], with a recent study highlighting the presence of CD206+ cells in inactive lesion centres, while iNOS expression was associated with areas of active pathology at lesion edges [88].